Impact of adjuvant immunotherapy on survival of patients with resected stage III melanoma diagnosed in 2003-2011 in the US

被引：0
|
作者：
Jang, S. [1 ]
Wang, H. [2 ]
Venna, S. [1 ]
机构：
[1] Inova Schar Canc Inst, Fairfax, VA USA
[2] Georgetown Univ, Washington, DC USA
来源：
MELANOMA RESEARCH | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FC2-2
引用
收藏
页码：E8 / E9
页数：2
相关论文
共 50 条
  • [31] Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews
    Ann Livingstone
    Kathy Dempsey
    Martin R. Stockler
    Kirsten Howard
    Georgina V. Long
    Matteo S. Carlino
    Alexander M. Menzies
    Rachael L. Morton
    [J]. BMC Cancer, 21
  • [32] Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era
    Hagopian, G.
    Jiang, X.
    Grant, C.
    Brazel, D.
    Kumar, P.
    Yamamoto, M.
    Jakowatz, J.
    Chow, W.
    Tran, T.
    Shen, W.
    Moyers, J.
    [J]. ESMO OPEN, 2024, 9 (02)
  • [33] Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1845 - 1855
  • [34] SURVIVAL IMPACT OF ADJUVANT CHEMOTHERAPY FOR RESECTED EARLY STAGE RECTAL ADENOCARCINOMA
    Tay, R.
    Jamnagerwalla, M.
    Steel, M.
    Wong, H. L.
    McKendrick, J. J.
    Faragher, I.
    Kosmider, S.
    Hastie, I.
    Desai, J.
    Harold, M.
    Gibbs, P.
    Wong, R.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 66 - 66
  • [35] Adjuvant Treatment For Patients With Surgically Resected Advanced-Stage Melanoma
    Grossmann, Kenneth F.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 633 - 635
  • [36] Utilization and Survival Benefit of Adjuvant Immunotherapy in Resected High-Risk Stage II Melanoma: A National Cancer Database Analysis
    Wong, W. G.
    Olecki, E.
    Stahl, K.
    Holguin, R. Perez
    Pameijer, C.
    Shen, C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S27 - S27
  • [37] The effect of delay of adjuvant chemotherapy on survival in patients with resected stage II and III gastric cancer.
    Jung, Minkyu
    Park, Hyoung Soon
    Park, Han Na
    Lim, Seungtaek
    Park, Ji Soo
    Chon, Hong Jae
    Kim, Hyoung-Il
    Ahn, Ji Yeong
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hye Ryun
    Kim, Hyo Song
    Rha, Sun Young
    Chung, Hyun Cheol
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma
    Dieng, Mbathio
    Lord, Sarah J.
    Turner, Robin M.
    Nieweg, Omgo E.
    Menzies, Alexander M.
    Saw, Robyn P. M.
    Einstein, Andrew J.
    Emmett, Louise
    Thompson, John F.
    Lo, Serigne N.
    Morton, Rachael L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2871 - 2881
  • [39] The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma
    Mbathio Dieng
    Sarah J. Lord
    Robin M. Turner
    Omgo E. Nieweg
    Alexander M. Menzies
    Robyn P. M. Saw
    Andrew J. Einstein
    Louise Emmett
    John F. Thompson
    Serigne N. Lo
    Rachael L. Morton
    [J]. Annals of Surgical Oncology, 2022, 29 : 2871 - 2881
  • [40] Calculation of survival of patients with stage III melanoma
    Berd, D
    Mastrangelo, MJ
    Sato, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9427 - 9427
12345